Literature DB >> 17970084

GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells.

Jing-Pin Lin1, Jai-Sing Yang, Nai-Wen Chang, Tsan-Hung Chiu, Chin-Cheng Su, Kung-Wen Lu, Yung-Tsuan Ho, Chin-Chung Yeh, Hui-Ju Lin, Jing-Gung Chung.   

Abstract

Berberine, an isoquinoline alkaloid, has been shown to possess anticancer properties in some cancer cell lines. Here, we report that in vitro treatment of cervical cancer Ca Ski cells with berberine decreased the percentage of viable Ca Ski cells in a dose-dependent and time-dependent manner. Berberine enhanced the apoptosis of Ca Ski cells with the induction of a higher ratio of p53 and Bax/Bcl-2 proteins, increased levels of reactive oxygen species (ROS) and Ca2+, disruption of the mitochondrial membrane potential, and promotion of caspase-3 activity. In CaSki cells pretreated with the pan-caspase inhibitor zVAD-fmk, the berberine-induced caspase-3 activity and apoptosis were significantly blocked as confirmed by flow cytometric analysis. Western blot also showed that berberine induced the expression of GADD153, a transcription factor involved in apoptosis. Thus berberine increased ROS levels leading to endoplasmic reticulum (ER) stress based on the increase of GADD153 and shown by Ca2+ release from the ER. When the Ca Ski cells were pretreated with catalase, GADD153 production was abrogated and apoptosis was significantly reduced.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970084

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

Review 1.  Endoplasmic-reticulum calcium depletion and disease.

Authors:  Djalila Mekahli; Geert Bultynck; Jan B Parys; Humbert De Smedt; Ludwig Missiaen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

2.  The protective effect of berberine on β-cell lipoapoptosis.

Authors:  N Gao; T-Y Zhao; X-J Li
Journal:  J Endocrinol Invest       Date:  2010-04-22       Impact factor: 4.256

3.  Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.

Authors:  Sutapa Mahata; Alok C Bharti; Shirish Shukla; Abhishek Tyagi; Syed A Husain; Bhudev C Das
Journal:  Mol Cancer       Date:  2011-04-15       Impact factor: 27.401

4.  The Anti-Apoptotic Role of Berberine in Preimplantation Embryo In Vitro Development through Regulation of miRNA-21.

Authors:  Chao Zhang; Ya-Ran Shi; Xiao-Ran Liu; Yong-Chun Cao; Di Zhen; Zi-Ye Jia; Jin-Qi Jiang; Jian-Hui Tian; Jian-Ming Gao
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

5.  Stevioside induced cytotoxicity in colon cancer cells via reactive oxygen species and mitogen-activated protein kinase signaling pathways-mediated apoptosis.

Authors:  Hai-Peng Ren; Xiao-Yan Yin; Hai-Ying Yu; Hai-Feng Xiao
Journal:  Oncol Lett       Date:  2017-02-14       Impact factor: 2.967

6.  Studies on the Dual Cytotoxicity and Antioxidant Properties of Berberis vulgaris Extracts and Its Main Constituent Berberine.

Authors:  Lamyae El Khalki; Mounir Tilaoui; Abdeslam Jaafari; Hassan Ait Mouse; Abdelmajid Zyad
Journal:  Adv Pharmacol Sci       Date:  2018-01-08

7.  Interaction of herbal compounds with biological targets: a case study with berberine.

Authors:  Xiao-Wu Chen; Yuan Ming Di; Jian Zhang; Zhi-Wei Zhou; Chun Guang Li; Shu-Feng Zhou
Journal:  ScientificWorldJournal       Date:  2012-11-13

8.  The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells.

Authors:  Bo Yoon Chang; Sae Am Kim; Bindu Malla; Sung Yeon Kim
Journal:  Toxicol Res       Date:  2011-06

Review 9.  The Natural Occurring Compounds Targeting Endoplasmic Reticulum Stress.

Authors:  Hai Liu; Jianqiong Yang; Linfu Li; Weimei Shi; Xiaoliang Yuan; Longhuo Wu
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-03       Impact factor: 2.629

Review 10.  Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization.

Authors:  Solomon Habtemariam
Journal:  Molecules       Date:  2020-03-20       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.